松松果
Lv21
150 积分
2023-03-11 加入
-
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024
2小时前
待确认
-
Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
2小时前
已完结
-
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
7天前
已完结
-
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability–High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
7天前
已完结
-
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
7天前
已完结
-
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
7天前
已完结
-
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
7天前
已完结
-
Multimodality Treatment for Locally Advanced Gastric Adenocarcinoma
8天前
已完结
-
Systematic perturbation screens identify regulators of inflammatory macrophage states and a role for TNF mRNA m6A modification
23天前
已完结
-
Humanized mouse liver reveals endothelial control of essential hepatic metabolic functions
1个月前
已完结